This site is intended for Healthcare professionals only.

USFDA completes inspection of Nagpur facility, no observation issued: Lupin


USFDA completes inspection of Nagpur facility, no observation issued: Lupin

New Delhi: Drug firm Lupin said the US health regulator has completed an inspection of its Nagpur facility in Maharashtra without any observation. The product-specific pre-approval inspection by USFDA concluded without any observation, Lupin said in a BSE filing.

Read Also:Lupin gets EIR from USFDA for Nagpur facility

 



Source: PTI
0 comment(s) on USFDA completes inspection of Nagpur facility, no observation issued: Lupin

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted